|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-1-11
|
|
pubmed:abstractText |
To evaluate the biliary penetration of ciprofloxacin and cefotaxime in patients with obstructed bile ducts and to determine simple predictive markers of effective biliary concentrations of these drugs.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0954-691X
|
|
pubmed:author |
pubmed-author:BazinChristopheC,
pubmed-author:BoytchevIsabelleI,
pubmed-author:BuffetCatherineC,
pubmed-author:ChouryAndré-DanielAD,
pubmed-author:Dhalluin-VenierValérieV,
pubmed-author:FarahRita BouRB,
pubmed-author:FritschJacquesJ,
pubmed-author:FurlanValérieV,
pubmed-author:MassiasLaurentL,
pubmed-author:PelletierGillesG,
pubmed-author:PratFrédéricF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
127-30
|
|
pubmed:dateRevised |
2009-10-16
|
|
pubmed:meshHeading |
pubmed-meshheading:18188033-Aged,
pubmed-meshheading:18188033-Aged, 80 and over,
pubmed-meshheading:18188033-Anti-Bacterial Agents,
pubmed-meshheading:18188033-Bile,
pubmed-meshheading:18188033-Bilirubin,
pubmed-meshheading:18188033-Cefotaxime,
pubmed-meshheading:18188033-Cholangiopancreatography, Endoscopic Retrograde,
pubmed-meshheading:18188033-Cholangitis,
pubmed-meshheading:18188033-Cholestasis,
pubmed-meshheading:18188033-Chromatography, High Pressure Liquid,
pubmed-meshheading:18188033-Ciprofloxacin,
pubmed-meshheading:18188033-Female,
pubmed-meshheading:18188033-Humans,
pubmed-meshheading:18188033-Male,
pubmed-meshheading:18188033-Middle Aged,
pubmed-meshheading:18188033-Prospective Studies
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Effects of biliary obstruction on the penetration of ciprofloxacin and cefotaxime.
|
|
pubmed:affiliation |
Hepatology, Le Kremlin Bicêtre, France. valerie.dhalluin@bct.aphp.fr
|
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial
|
